
Echosens and United Digestive Forge Partnership to Enhance Non-Invasive Liver Diagnostics
BOSTON, MA – July 15, 2025 – Echosens, a global leader in non-invasive diagnostic solutions for liver diseases, is pleased to announce a strategic partnership with United Digestive, a prominent provider of gastroenterology and hepatology services. This collaboration is set to significantly expand access to advanced non-invasive liver diagnostics for patients across the United States.
The partnership signifies a shared commitment by both organizations to improve patient outcomes and streamline the diagnostic process for liver conditions. By integrating Echosens’ state-of-the-art FibroScan® technology into United Digestive’s extensive network of clinics, patients will benefit from convenient and accurate assessments of liver health, without the need for invasive procedures.
FibroScan® is a revolutionary device that utilizes transient elastography to measure liver stiffness and fat content, providing crucial information for the diagnosis and management of various liver diseases, including fibrosis, steatosis (fatty liver), and cirrhosis. Its non-invasive nature makes it a preferred diagnostic tool for both clinicians and patients, offering a safer and more comfortable alternative to traditional liver biopsies.
“We are thrilled to partner with United Digestive, a leader in digestive health,” said [Name and Title of Echosens Representative, if available in the original press release, otherwise omit or use a generic placeholder]. “This collaboration aligns perfectly with our mission to make advanced liver diagnostics more accessible. United Digestive’s extensive reach and dedication to patient care make them an ideal partner to bring the benefits of FibroScan® to a broader patient population.”
United Digestive’s commitment to providing comprehensive and cutting-edge care for gastrointestinal and liver disorders makes this partnership a natural fit. By incorporating FibroScan® into their practice, United Digestive will empower their physicians with a powerful tool to identify liver disease early, enabling timely intervention and personalized treatment plans.
“[Name and Title of United Digestive Representative, if available in the original press release, otherwise omit or use a generic placeholder] commented, “At United Digestive, we are continuously seeking innovative ways to enhance our patient care. The integration of Echosens’ FibroScan® technology represents a significant step forward in our ability to diagnose and manage liver conditions. This non-invasive approach will not only improve the patient experience but also allow for more efficient and effective management of liver health.”
This strategic alliance is expected to have a profound impact on the landscape of liver disease diagnostics in the United States, facilitating earlier detection, better patient management, and ultimately, improved quality of life for individuals affected by liver conditions. Patients seeking liver health assessments at United Digestive locations will now have access to this advanced, non-invasive technology.
Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
www.prnewswire.com published ‘Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics’ at 2025-07-15 11:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.